diabetes prevention News
-
Coloplast and the World Diabetes Foundation prevent amputations in India
Coloplast"s donation programme Access to Healthcare just signed a contract with the World Diabetes Foundation (WDF) about a new healthcare project in India. The project aims to improve the treatment of diabetic wounds. "Every single day, 110 Indians have a foot or part of their leg amputated due to diabetic foot ulcers, and an unknown number die before they are even diagnosed," says Per Ole ...
-
Independence Blue Cross and Podimetrics Collaborate to Prevent Diabetic Amputations
PHILADELPHIA and SOMERVILLE, Mass., October 26, 2021 — Independence Blue Cross (Independence) and Podimetrics, a virtual care management company dedicated to preventing diabetic amputations, today announced an agreement for Podimetrics to remotely monitor Independence fully insured commercial members who have diabetes and a history of a diabetic foot ulcer with the use of the ...
-
Novo Nordisk praises historic declaration to fight diabetes
On December 13, 2010, twenty-two countries from the Middle East and Northern Africa (MENA) and five international organisations agreed on the "Dubai Declaration on Diabetes and Chronic Non-Communicable Diseases in the Middle East and Northern Africa Region." The agreement was the culmination of the Novo Nordisk sponsored MENA Diabetes Leadership Forum held on December 12-13 in Dubai. "We are ...
-
Digital Diagnostics, Kingdom of Saudi Arabia Sign Intent to Provide Preventative Diabetic Healthcare to 35M
CORALVILLE, IOWA July 21, 2022 – Leadership from Digital Diagnostics – maker of IDx-DR, the first-ever FDA-cleared, fully autonomous AI system for the diagnosis of diabetic retinopathy – signed a memorandum of understanding (MOU) with the Kingdom of Saudi Arabia’s Ministry of Investment during a ceremonial visit with United States of America President Joe Biden. With this ...
-
Immunological analysis of prevention trial with Diamyd published in peer-reviewed scientific journal
Results of an analysis of a previous prevention trial with Diamyd® (GAD-alum) treatment, which indicate a positive and sustained immunomodulating effect after treatment with Diamyd® in healthy children at risk for type 1 diabetes, have been published in the scientific journal Journal of Immunology Research. The analysis was carried out by researchers at Lund University and provides ...
-
Podimetrics Congratulates Department of Veterans Affairs Partner Suzanne Shirley on Winning the Service to the Citizen Award
VA Innovation Ecosystem leader recognized for the Initiative to End Diabetic Limb Loss. SOMERVILLE, Mass., June 29, 2021 — Podimetrics, a virtual care management company dedicated to preventing costly and deadly diabetic amputations, congratulates Suzanne Shirley today on winning the Service to Citizen Award in recognition for her leadership and dedication to the Veteran population ...
-
Research Finds Nearly 40% of Diabetes Patients who Suffer a Lower Extremity Amputation Endure Another Within Five Years
Reamputation Rates Have Not Improved Over Two Decades. SOMERVILLE, Mass., June 10, 2021 — Podimetrics, a virtual care management company dedicated to preventing costly and deadly diabetic amputations, today announced results from its latest research, which found patients with diabetes who have an amputation have a 37 percent chance of having reamputation within five years. The ...
-
Podimetrics Secures $45 Million Series C To Help At-Risk Providers and Health Plans Prevent Diabetic Amputations in High-Risk Patients
SOMERVILLE, Mass., March 24, 2022 — Podimetrics, creator of the FDA-cleared SmartMat™ and integrated clinical care services that can help save the limbs and lives of complex patients with diabetes, today announced a $45 million Series C round led by D1 Capital Partners, along with two new investors, the Medtech Convergence Fund and an undisclosed strategic investor. Existing ...
-
Defymed at ATTD 2023
22-25 February (Berlin, Germany): Defymed at the Advanced Technologies and treatments for Diabetes. The purpose of the ATTD meeting is to highlight innovative technologies and treatments in diabetes management. It brings together developers of new technologies with the diabetes professionals and caretakers, researchers, industries, startup companies, investors, reimbursement authorities and ...
By Defymed
-
Podimetrics Expands Advisory Board and Closes Funding Round to Broaden Access to Virtual Care for Vulnerable Patients
Following booming growth period, virtual diabetes care management company receives additional Series B funding and adds to team of expert advisors SOMERVILLE, Mass., August 19, 2020 — Podimetrics, a virtual care management company with the leading solution to help prevent costly and deadly diabetic amputations, announced that Dr. Foluso Fakorede, Doug Ghertner and David Joyner have ...
-
First patient enrolled in Diamyd Medical`s Phase III trial Diagnode-3
The first patient has now received its first intralymphatic injection of Diamyd® in the precision medicine Phase III trial DIAGNODE-3. The trial will include approximately 330 patients aged 12 to 29 years newly diagnosed with Type 1 Diabetes who carry the genetically defined haplotype HLA DR3-DQ2. “The fact that the first patient is now enrolled in DIAGNODE-3 is a major milestone for ...
-
NHS Long Term Plan gives thousands of life changing diabetes monitors
Nearly 30,000 people across the country with Type 1 diabetes have received life-changing diabetes monitors through the NHS Long Term Plan. The innovative device, which is the size of a £2 coin and worn on the arm, means people with Type 1 do not have to carry out multiple painful finger-prick checks to monitor their blood sugar levels. Instead, people with the condition can monitor their ...
-
Research Finds All-Cause Hospitalizations are Nearly Three Times More Likely During a Diabetic Foot Ulcer Episode
SOMERVILLE, Mass., January 18, 2022 — Podimetrics, a virtual care support company dedicated to preventing costly and deadly diabetic amputations, today announced results from its latest research, which compared the health of individuals during and after periods of diabetic foot ulceration — open sores or wounds on the foot, which commonly occur among those with diabetes and are the ...
-
World Diabetes Day
An estimated 415 million people are living with diabetes in the world. Diabetes is a chronic disease, that causes blood sugar levels in your body to become too high, either due to your body not being able to respond properly to insulin or due to your body not being unable to produce any at all. If left untreated, this can lead to serious complications such as heart attack, stroke, obesity, eye ...
-
Podimetrics Adds Senator Bob Kerrey to Advisory Board, Expands Executive Leadership Team to Support Company Growth
The additions come at a critical point in the virtual care management company’s growth. SOMERVILLE, Mass., March 11th, 2021 — Podimetrics, a virtual care management company dedicated to preventing costly and deadly diabetic amputations, announced today the additions of Senator Bob Kerrey to its advisory board and three new hires to its executive leadership team. Former Blue ...
-
Georgia`s cyclists are pedaling hard to stop diabetes at local tour de cure event
Morgan Kendrick, President of Blue Cross and Blue Shield of Georgia, Appointed as Tour de Cure Executive Sponsor. In an effort to reduce the growing prevalence of diabetes, Blue Cross and Blue Shield of Georgia (BCBSGa), is the premiere sponsor of the Atlanta Tour de Cure® (TDC) on Sunday, May 15, 2011 at Bouckaert Farm in Fairburn, Georgia. This multi-faceted ride is the American Diabetes ...
-
AVM Biotechnology Awarded $1.6 Million Phase II SBIR Grant to Study AVM0703’s Potential to Reverse Type 1 Diabetes
AVM Biotechnology, LLC, a clinical stage company advancing AVM0703 in the treatment of Non-Hodgkin’s Lymphoma (NHL)/Leukemia, today announced that it has been awarded a Phase II Small Business Innovation Research (SBIR) grant. This $1.6 million award from the National Institute of Diabetes and Digestive Kidney Disease (NIDDK) will allow the company to pursue additional research in the use ...
-
2,000,000 TWO2 Treatments Milestone Reached as TWO2 Study Is Highlighted in Systemic Review of Topical Oxygen Therapies
Advanced Oxygen Therapy Inc. (AOTI) today announced that 2,000,000 treatments of its unique cyclical-pressure Topical Wound Oxygen (TWO2) therapy have now been applied by patients safely at home. Additionally, a high-quality paper published on April 19, 2021 in the journal Diabetic Medicine, entitled Topical oxygen therapy for diabetes-related foot ulcers: A systematic review and ...
-
Study: Pathbreaking Technology Completely Eliminated Major Diabetic Amputations
Research conducted by Kaiser Permanente also found once-daily remote temperature monitoring with Podimetrics decreased overall resource utilization SOMERVILLE, Mass., October 14, 2020 — Podimetrics, a virtual care management company with the leading solution to help prevent costly and deadly diabetic amputations, today announced results from its latest study of patients at high risk of ...
-
Evolve BioSystems, Inc. Announces the Use of Activated B. infantis EVC001 by International Consortium to Study the Prevention of Type 1 Diabetes in Children
Evolve BioSystems, Inc. today announces that its product, activated B. infantis EVC001, will be used in one of the largest international clinical studies on preventing type 1 diabetes (T1D) in genetically predisposed children. The randomized, controlled, double-blind, multicenter trial will be conducted across eight major research centers in five European countries. The Leona M. and Harry B. ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you